LEADER 01762nam  2200445Ia 450 
001 9910699126003321
005 20230902162127.0
035   $a(CKB)5470000002400638
035   $a(OCoLC)464670680
035   $a(EXLCZ)995470000002400638
100   $a20091110d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ePAT, a framework for innovative pharmaceutical development, manufacturing, and quality assurance
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2004]
215   $a1 online resource (16 pages)
300   $a"Center for Veterinary Medicine (CVM)."
300   $a"Office of Regulatory Affairs (ORA)."
300   $a"Pharmaceutical CGMPs."
300   $a"September 2004."
320   $aIncludes bibliographical references (page 16).
517   $aGuidance for industry 
606   $aDrug development$xGovernment policy$zUnited States
606   $aDrug factories$xGovernment policy$zUnited States
606   $aQuality assurance$xGovernment policy$zUnited States
615  0$aDrug development$xGovernment policy
615  0$aDrug factories$xGovernment policy
615  0$aQuality assurance$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Veterinary Medicine (U.S.)
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Regulatory Affairs.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699126003321
996   $aGuidance for industry$93434577
997   $aUNINA